Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study

被引:0
作者
Patrick J. van der Geest
Nicole G. M. Hunfeld
Sophie E. Ladage
A. B. Johan Groeneveld
机构
[1] Erasmus University Medical Center,Department of Intensive Care Medicine
[2] Erasmus University Medical Center,Department of Pharmacy
来源
BMC Infectious Diseases | / 16卷
关键词
Critically ill; Micafungin; Anidulafungin; Invasive candidiasis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] What’s new in the clinical and diagnostic management of invasive candidiasis in critically ill patients
    Cristóbal León
    Luis Ostrosky-Zeichner
    Mindy Schuster
    Intensive Care Medicine, 2014, 40 : 808 - 819
  • [22] What's new in the clinical and diagnostic management of invasive candidiasis in critically ill patients
    Leon, Cristobal
    Ostrosky-Zeichner, Luis
    Schuster, Mindy
    INTENSIVE CARE MEDICINE, 2014, 40 (06) : 808 - 819
  • [23] Candidemia and invasive candidiasis approach in critically ill patients: role of the echinocandins
    Almirante, Benito
    Garnacho-Montero, Jose
    Maseda, Emilio
    Javier Candel, Francisco
    Grau, Santiago
    Guinea, Jesus
    Moreno, Ignacio
    Munoz, Patricia
    Ruiz-Santana, Sergio
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2017, 30 (05) : 355 - 367
  • [24] Efficacy of micafungin for the treatment of invasive candidiasis and candidaemia in patients with neutropenia
    Chandrasekar, Pranatharthi
    Sirohi, Bhawna
    Seibel, Nita L.
    Hsu, Jack W.
    Azie, Nkechi
    Wu, Chunzhang
    Ruhnke, Markus
    MYCOSES, 2018, 61 (05) : 331 - 336
  • [25] Invasive fungal infection in critically ill patient: role of micafungin
    Nieto Cabrera, Mercedes
    Escudero Lopez-Cepero, Elena
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2012, 25 (01) : 4 - 9
  • [26] Head-to-head comparison of micafungin versus caspofungin in the treatment of invasive candidiasis
    Michael A. Pfaller
    Current Fungal Infection Reports, 2009, 3 (3) : 127 - 128
  • [27] Pharmacokinetics of anidulafungin in critically ill patients with Candida peritonitis
    Perez Civantos, D. V.
    Robles Marcos, M.
    Azanza Perea, J. R.
    Pazos Pacheco, C.
    Garcia-Montoto Perez, F.
    Jerez Gomez-Coronado, V.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2019, 86 : 142 - 146
  • [28] PHARMACOKINETICS OF MICAFUNGIN IN PEDIATRIC PATIENTS WITH INVASIVE CANDIDIASIS AND CANDIDEMIA
    Undre, Nasrullah A.
    Stevenson, Paul
    Freire, Antonio
    Arrieta, Antonio
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (06) : 630 - 632
  • [29] Anidulafungin Pharmacokinetics in Ascites Fluid and Pleural Effusion of Critically Ill Patients
    Welte, R.
    Eller, P.
    Lorenz, I.
    Joannidis, M.
    Bellmann, R.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (04)
  • [30] Mind the gaps: challenges in the clinical management of invasive candidiasis in critically ill patients
    Pecanha-Pietrobom, Paula M.
    Colombo, Arnaldo Lopes
    CURRENT OPINION IN INFECTIOUS DISEASES, 2020, 33 (06) : 441 - 448